Detalhe da pesquisa
1.
The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironment.
Nat Commun
; 15(1): 1700, 2024 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38402224
2.
Nivolumab and Relatlimab in Patients With Advanced Melanoma That Had Progressed on Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy: Results From the Phase I/IIa RELATIVITY-020 Trial.
J Clin Oncol
; 41(15): 2724-2735, 2023 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36780608
3.
VOTRAGE study: Phase I dose-escalation study of pazopanib in unfit older patients.
J Geriatr Oncol
; 12(5): 759-764, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33715996